N2-(N,N-Dimethylaminomethylene)-3-[2-(4-nitrophenyl)ethyl]-1',2'-di-O-(trimethylsilyl)biopterin (4) was prepared from biopterin (1a, 86% overall yield) in 5 steps. Glycosylation of 4 with 1,2,3,5-tetra-O-acetyl-β-D-ribofuranose (5a) and its 2,3,5-tri-O-benzoyl analog (5b) respectively afforded the corresponding 2'-O-(2,3,5-tri-Oacetyl- and 2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)biopterin derivatives (6a, 42% and 6b, 60%) as major products. Removal of the protecting groups of 6b provided 2'-O-(β-D-ribofuranosyl)biopterin (1c, 87% overall yield) in 3 steps.
Summary Treatment of L-biopterin (I) with N,N-dimethyformamide dimethyl- (or diethyl)acetal and then with acetic anhydride in pyridine gave 1',2'-di-O-acetyl-N'-(N,N-dimethylaminomethylene)-L-biopterin (4), which was converted by the Mitsunobu reaction into 3-methyl (5) and 3-p-nitrophenetyl derivatives (7). The protective groups on the side chain diols and N2 of these compounds were selectively cleaved to furnish products 6, 8-10, among which 9 is naturally occurring 3-methyl-L-biopterin and 8 is N',N(3)-protected biopterin, a versatile intermediate for various reactions on the side-chain diol. In contrast, the same Mitsunobu reactions of tri-N2:I',2'-0-acetyl-L-biopterin (II) afforded 04-methyl (12) and 04-NPE derivatives (13), both of which yielded 0 4-methyl-L-biopterin (14) and subsequently led to 4-amino-L-biopterin (18).
A series of side chain reactions starting from the 6-and 7-styryl-substituted 1,3-dimethyllumazines 1 and 21 as well as from the 6-and 7-[2-(methoxycarbonyl)ethenyl]-substituted 1,3-dimethyllumazine 2 and 22 were performed first by addition of Br 2 to the C¼C bond forming the 1',2'-dibromo derivatives 3, 4, 24, and 26 in high yields (Schemes 1 and 3) (lumazine ¼ pteridine-2,4(1H,3H)-dione). Treatment of 3 with various nucleophiles gave rise to an unexpected tele-substitution in 7-position and elimination of the Br-atoms generating 7-alkoxy-(see 5 and 6), 7-hydroxy-(see 7) and 7-amino-6-styryl-1,3-dimethyllumazines (see 8 -11) (Scheme 1). On the other hand, 4 underwent, with dilute DBU (1,8-diazabicyclo[5.4.0]undec-2-ene), a normal HBr elimination in the side chain leading to 18, whereas treatment with MeONa afforded a more severe structural change to 19. Similarly, 24 and 26 reacted to 27, 32, and 33 under mild conditions, whereas in boiling NaOMe/MeOH, 24 gave 7-(2-dimethoxy-2-phenylethyl)-1,3dimethyllumazine (30) which was hydrolyzed to give 31 (Scheme 3). From the reactions of 4 and 24 with DBU resulted the dark violet substance 20 and 25, respectively, in which DBU was added to the side chain (Scheme 2). The styryl derivatives 1 and 21 could be converted, by a Sharpless dihydroxylation reaction, into the corresponding stereoisomeric 6-and 7-(1,2-dihydroxy-2-phenylethyl)-1,3-dimethyllumazines 34 -37 (Scheme 4). The dihydroxy compounds 34 and 35 were also acetylated to 38 and 39 which, on catalytic reduction followed by formylation, yielded the diastereoisomer mixtures 40 and 41. Deacetylation to 42 and 45 allowed the chromatographic separation of the diastereoisomers resulting in the isolation of 43 and 44 as well as 46 and 47, respectively. Introduction of a 6-or 7-ethynyl side chains proceeded well by a Sonogashira reaction with 6-(48) or 7-chloro-1,3-dimethyllumazine (55) yielding 49 -51 and 56 -58 (Scheme 5). The direction of H 2 O addition to the triple bond is depending on the substituents since the 6-(49) and 7-(phenylethynyl)-1,3-dimethyllumazine (56) showed attack at the 2'position yielding 53 and 60, in contrast to the 6-(51) and 7-ethynyl-1,3-dimethyllumazine (58) favoring attack at C(1') and formation of 6-(52) and 7-acetyl-1,3-dimethyllumazine (59).
No abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.